01—Abstract
Summary
Summary of the 8-K filed October 1, 2025. Cited figures are marked; the original filing is the authoritative source.
On September 30, 2025, Omega Healthcare Investors, Inc. entered into a new senior unsecured $2.3 billiona credit facility, consisting of a $2.0 billion multicurrency revolving credit facility and a $300.0 million delayed draw term loan (DDTL) facility.
The Amended and Restated Credit Agreement, dated as of September 30, 2025, replaces Omega's previous $1.45 billionb 2021 Revolving Credit Facility, which was scheduled to expire on October 30, 2025, and that prior facility was terminated. The Revolving Credit Facility matures on September 28, 2029, with two six-month extension options, and the DDTL Credit Facility matures on September 29, 2028, with two twelve-month extension options. The Credit Facility may be drawn in U.S. Dollars, Euros, British Pounds Sterling and Canadian Dollars, and Omega may increase maximum aggregate commitments to $3.0 billion, subject to customary conditions.
Omega also entered into a First Amendment to its existing $428.5 millionc term loan credit agreement, dated August 8, 2023. The amendment reduces the interest rate margins to a range from 1.60% to 0.800% for SOFR-based loans and from 0.60% to 0% for base rate advances, and removes the 0.100% interest rate step-up for each extension period. The current maturity of the term loan is August 8, 2026, subject to one additional 12-month extension option.
As of September 30, 2025, Omega had no borrowings outstanding under the new Credit Facility and $428.5 milliond outstanding under the Term Loan Credit Agreement. The Credit Agreement contains covenants setting maximum total leverage, maximum secured leverage, maximum unsecured leverage, minimum fixed charge coverage, minimum consolidated tangible net worth and minimum unsecured interest coverage.
The filing states that Omega did not experience any material early termination penalties from terminating the prior revolver. Omega described the purposes of the new facility as refinancing existing indebtedness, financing acquisitions, and funding working capital, capital expenditures and other general corporate purposes.
02—Key points
Key Highlights
- New $2.3 billion senior unsecured credit facility: a $2.0 billion multicurrency revolver and a $300.0 million delayed draw term loan, effective September 30, 2025.
- Replaced the prior $1.45 billion 2021 Revolving Credit Facility, which was scheduled to expire on October 30, 2025, and was terminated with no material early termination penalties.
- Initial pricing on the revolver is Term SOFR plus 1.050% with a 0.250% facility fee, and the DDTL is initially priced at Term SOFR plus 1.200%, based on the Company's debt ratings.
- Accordion feature allows Omega to increase maximum aggregate commitments to $3.0 billion, subject to customary conditions.
- Revolver matures September 28, 2029 (with two six-month extension options); DDTL matures September 29, 2028 (with two twelve-month extension options).
- First Amendment reduces margins on the existing $428.5 million term loan (reduction of 35 basis points) and removes the 0.100% step-up for extension periods; the term loan matures August 8, 2026, subject to one 12-month extension.
- As of September 30, 2025, no borrowings were outstanding under the new Credit Facility; $428.5 million was outstanding under the Term Loan Credit Agreement.
03—Questions
Frequently Asked Questions
What changed in Omega's credit facilities?
Omega closed a new $2.3 billion senior unsecured credit facility, consisting of a $2.0 billion revolving credit facility and a $300.0 million delayed draw term loan, which replaced its prior $1.45 billion revolver. It also amended its $428.5 million term loan to lower interest rate margins and remove an extension-period step-up.
When do the new facilities mature?
The Revolving Credit Facility matures on September 28, 2029, with Omega's option to extend for two six-month periods. The DDTL Credit Facility matures on September 29, 2028, with options to extend for two twelve-month periods. The existing term loan matures August 8, 2026, subject to one additional 12-month extension option.
How will the new revolver be priced?
The Revolving Credit Facility is initially priced at Term SOFR plus 1.050% based on Omega's debt ratings, plus a facility fee of 0.250%. The DDTL Credit Facility is initially priced at Term SOFR plus 1.200%. The filing states that the applicable margins follow a performance grid tied to investment grade ratings, and that a ticking fee of 0.25% per annum on undrawn DDTL commitments begins accruing December 29, 2025.
Why did Omega enter into these agreements, and what does the filing say about its borrowing capacity?
Omega expects to use the Credit Facility to refinance existing indebtedness, finance acquisitions, and fund working capital, capital expenditures and other general corporate purposes. The Credit Facility includes an accordion feature allowing aggregate commitments of up to $3.0 billion, and as of September 30, 2025, no borrowings were outstanding under it.
04—Continue